JP2020514689A5 - - Google Patents

Download PDF

Info

Publication number
JP2020514689A5
JP2020514689A5 JP2019531802A JP2019531802A JP2020514689A5 JP 2020514689 A5 JP2020514689 A5 JP 2020514689A5 JP 2019531802 A JP2019531802 A JP 2019531802A JP 2019531802 A JP2019531802 A JP 2019531802A JP 2020514689 A5 JP2020514689 A5 JP 2020514689A5
Authority
JP
Japan
Prior art keywords
antigen
biological sample
timp1
lrg1
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019531802A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020514689A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/066851 external-priority patent/WO2018112428A1/en
Publication of JP2020514689A publication Critical patent/JP2020514689A/ja
Publication of JP2020514689A5 publication Critical patent/JP2020514689A5/ja
Priority to JP2023011264A priority Critical patent/JP2023055806A/ja
Priority to JP2025080930A priority patent/JP2025118850A/ja
Pending legal-status Critical Current

Links

JP2019531802A 2016-12-15 2017-12-15 膵管腺癌の検出および処置のための方法 Pending JP2020514689A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023011264A JP2023055806A (ja) 2016-12-15 2023-01-27 膵管腺癌の検出および処置のための方法
JP2025080930A JP2025118850A (ja) 2016-12-15 2025-05-14 膵管腺癌の検出および処置のための方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662435024P 2016-12-15 2016-12-15
US201662435020P 2016-12-15 2016-12-15
US62/435,020 2016-12-15
US62/435,024 2016-12-15
PCT/US2017/066851 WO2018112428A1 (en) 2016-12-15 2017-12-15 Methods for the detection and treatment of pancreatic ductal adenocarcinoma

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023011264A Division JP2023055806A (ja) 2016-12-15 2023-01-27 膵管腺癌の検出および処置のための方法

Publications (2)

Publication Number Publication Date
JP2020514689A JP2020514689A (ja) 2020-05-21
JP2020514689A5 true JP2020514689A5 (enExample) 2021-02-04

Family

ID=62559366

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019531802A Pending JP2020514689A (ja) 2016-12-15 2017-12-15 膵管腺癌の検出および処置のための方法
JP2023011264A Pending JP2023055806A (ja) 2016-12-15 2023-01-27 膵管腺癌の検出および処置のための方法
JP2025080930A Pending JP2025118850A (ja) 2016-12-15 2025-05-14 膵管腺癌の検出および処置のための方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023011264A Pending JP2023055806A (ja) 2016-12-15 2023-01-27 膵管腺癌の検出および処置のための方法
JP2025080930A Pending JP2025118850A (ja) 2016-12-15 2025-05-14 膵管腺癌の検出および処置のための方法

Country Status (6)

Country Link
US (3) US20200182876A1 (enExample)
EP (1) EP3555628A4 (enExample)
JP (3) JP2020514689A (enExample)
KR (1) KR102549063B1 (enExample)
CN (1) CN110121647A (enExample)
WO (1) WO2018112428A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160282351A1 (en) * 2013-10-28 2016-09-29 Salivatech Co., Ltd. Salivary biomarkers for cancers, methods and devices for assaying the same, and methods for determining salivary biomarkers for cancers
CN110646554B (zh) * 2019-09-12 2022-05-13 北京博远精准医疗科技有限公司 基于代谢组学的胰腺癌诊断标志物及其筛选方法和应用
RU2745793C1 (ru) * 2020-02-26 2021-04-01 Государственное бюджетное учреждение здравоохранения города Москвы городская клиническая больница имени С.П. Боткина департамента здравоохранения города Москвы (ГБУЗ ГКБ им. С.П. Боткина ДЗМ) Способ расчета средней продолжительности жизни у пациентов с метастатической аденокарциномой поджелудочной железы
CN115125312B (zh) * 2021-03-26 2025-07-18 中国科学院上海营养与健康研究所 用于Basal型胰腺导管腺癌(PDAC)诊断的标志物组合及其应用
CN113777309A (zh) * 2021-09-07 2021-12-10 复旦大学附属肿瘤医院 自身抗体在制备胰腺导管腺癌诊断试剂盒中的应用
CN113917008A (zh) * 2021-09-09 2022-01-11 广州济士源生物技术有限公司 质谱检测尿液中代谢物水平的产品在制备用于早期评估肠道息肉和结直肠癌产品中的应用
CN114487201A (zh) * 2022-02-09 2022-05-13 江西省肿瘤医院(江西省第二人民医院、江西省癌症中心) 鼻咽癌相关尿液标志物组合的检测试剂的应用
CN118742810A (zh) * 2022-02-15 2024-10-01 凯德药业股份有限公司 从免疫疗法预测不良事件
WO2024059549A2 (en) * 2022-09-12 2024-03-21 Board Of Regents, The University Of Texas System Methods for the detection and treatment of pancreatic ductal adenocarcinoma

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008063479A2 (en) * 2006-11-17 2008-05-29 Fred Hutchinson Cancer Research Center Pancreatic cancer biomarkers
SG10201405975VA (en) * 2009-10-01 2014-11-27 Phenomenome Discoveries Inc Serum-based biomarkers of pancreatic cancer and uses thereof for diseasedetection and diagnosis
JP6219300B2 (ja) * 2011-11-30 2017-10-25 メタノミクス ヘルス ゲーエムベーハー 膵臓癌を診断するための装置及び方法
US20140271621A1 (en) * 2013-03-14 2014-09-18 Abbott Laboratories Methods of prognosis and diagnosis of pancreatic cancer
US20160282351A1 (en) * 2013-10-28 2016-09-29 Salivatech Co., Ltd. Salivary biomarkers for cancers, methods and devices for assaying the same, and methods for determining salivary biomarkers for cancers
ES2698374T3 (es) * 2013-12-20 2019-02-04 Metanomics Health Gmbh Medios y procedimientos de diagnóstico de cáncer pancreático en un sujeto basándose en un panel de metabolitos
WO2015157557A1 (en) * 2014-04-09 2015-10-15 Myriad Rbm, Inc. Methods of diagnosing pancreatic cancer and methods related thereto
KR20160045547A (ko) * 2014-10-17 2016-04-27 에스케이텔레콤 주식회사 췌장암 진단용 조성물 및 이를 이용한 췌장암 진단방법

Similar Documents

Publication Publication Date Title
Richardson et al. Role of serological tests in the diagnosis of mold infections
Leligdowicz et al. Validation of two multiplex platforms to quantify circulating markers of inflammation and endothelial injury in severe infection
JP2020510816A5 (enExample)
Brekelmans et al. Smelling the diagnosis: the electronic nose as diagnostic tool in inflammatory arthritis. A case-reference study
JP2020526747A5 (enExample)
JP2008533471A5 (enExample)
WO2016163539A1 (ja) 肝疾患の病態を判別する方法
Kamada et al. Reevaluation of a lectin antibody ELISA kit for measuring fucosylated haptoglobin in various conditions
EP3440465A2 (en) Methods and systems for metabolite and/or lipid-based detection of colorectal cancer and/or adenomatous polyps
WO2006026020A3 (en) Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
JP2018509934A5 (enExample)
JP2023545017A5 (enExample)
Cristaudo et al. Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesothelioma
PL1776587T3 (pl) Zastosowanie C3A i jego pochodnych jako biomarkera do leczenia gruczolaka i/lub raka jelita grubego; metody diagnostyczne i testy z ich użyciem
Wu et al. Development of a highly sensitive glycan microarray for quantifying AFP-L3 for early prediction of hepatitis B virus–related hepatocellular carcinoma
JP7179356B2 (ja) 代謝物分析を利用したベーチェット病の診断方法
CN113791221A (zh) 一种检测急性主动脉夹层的生物标志物及其应用
JP2018529931A5 (enExample)
Fatela-Cantillo et al. Prognostic value of plasmatic tumor M2 pyruvate kinase and carcinoembryonic antigen in the survival of colorectal cancer patients
JP7650538B2 (ja) 血液由来エクソソームから見出した新規アルツハイマー病診断用バイオマーカー及びそれを用いたアルツハイマー病診断方法
Lippi et al. Diagnostic accuracy of the ultrasensitive S-PLEX SARS-CoV-2 N electrochemiluminescence immunoassay
Mukherjee et al. In-cell Western™ detection of organic cation transporters in bronchial epithelial cell layers cultured at an air–liquid interface on Transwell® inserts
Borrebaeck et al. Antibody array generation and use
WO2015164617A1 (en) Tuberculosis biomarkers in urine and uses thereof
Sogawa et al. Serum fibrinogen alpha C‐chain 5.9 k D a fragment as a biomarker for early detection of hepatic fibrosis related to hepatitis C virus